ClinicalTrialsFinder

Idiopathic Thrombocytopenic Purpura Clinical Trials in Belgrade

1 recruitingBelgrade, Serbia

Showing 1–1 of 1 trials

Recruiting
Phase 2Phase 3

A Study of Efgartigimod IV in Participants From 12 Years to Less Than 18 Years of Age With Chronic Immune Thrombocytopenia (ITP)

Immune Thrombocytopenic PurpuraITPIdiopathic Thrombocytopenic Purpura+4 more
argenx24 enrolled20 locationsNCT07194850